Glaukos Corporation (GKOS) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Glaukos Corporation
Glaukos Corporation is led by CEO Thomas William Burns, employs 1,094 people, headquartered in Aliso Viejo, US, publicly traded since 2015.
Glaukos Corporation (GKOS) stock trades at $178.88 with a market capitalization of $10.55B. The stock is valued at a negative price-to-earnings (P/E) ratio of -50.38, reflecting a net loss over the last twelve months, price-to-book of 14.02, price-to-sales of 15.76. Over the past 52 weeks the stock has ranged between $73.16 and $191.62, and currently trades 6.6% below its 52-week high.
On profitability, Glaukos Corporation generates a return on equity (ROE) of -27.07% (negative, reflecting a net loss), return on capital employed of -9.84%, an operating margin of -17.16%, a net profit margin of -30.68%.
Glaukos Corporation by the numbers, 2016–2025
Between 2016 and 2025 Glaukos Corporation reported revenue of $114.0M rising to $507.0M, a change of +344.7% across 10 years. Compounded, revenue has grown 17.6% a year over five years, 21.4% over three, 32.4% over the last twelve months. Net profit fell to $-188.0M.
Operating margin went from 3.7% in 2016 to -17.1% in 2025, a fall of 20.8 percentage points. The most recent net margin is -30.68%. On a trailing twelve-month basis to Jun '26, revenue is $614.0M and net profit $-188.0M.
Borrowings stand at $140.0M, cash from operations was $-46.0M in the latest year, positive in 4 of the last 10.
Return on equity has averaged -20.8% over five years, and was -28.7% in the most recent year.
The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
Glaukos Corporation (GKOS) — frequently asked questions
What is Glaukos Corporation (GKOS) stock price today?
Glaukos Corporation (GKOS) is currently trading at $178.88, up 1.24% today.
What is GKOS P/E ratio?
Glaukos Corporation's P/E ratio is -50.38. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is GKOS return on equity (ROE)?
Glaukos Corporation's return on equity (ROE) is -27.07%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Glaukos Corporation's market cap?
Glaukos Corporation has a market capitalization of $10.55B.
Does GKOS pay a dividend?
Glaukos Corporation is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does GKOS carry?
Glaukos Corporation has a debt-to-equity ratio of 0.15. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is GKOS's profit margin?
Glaukos Corporation reports a net profit margin of -30.68% — the share of revenue left after every cost, including tax and interest.
What sector is GKOS in?
Glaukos Corporation is classified under Healthcare, in the Medical - Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is GKOS listed on?
Glaukos Corporation trades on NYSE under the ticker GKOS.
What is GKOS's 52-week range?
Over the last year Glaukos Corporation has traded between $73.16 and $191.62.
Related Healthcare Stocks
Popular Stocks
Screens GKOS currently matches
On the figures above, Glaukos Corporation passes the filters for 6 of our ready-made screens, among them Low Debt Stocks, Large Cap Stocks, NYSE Listed Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.